` SFZN (Siegfried Holding AG) vs Swiss Market Index Comparison - Alpha Spread

SFZN
vs
Swiss Market Index

Over the past 12 months, SFZN has underperformed Swiss Market Index, delivering a return of -1% compared to the Swiss Market Index's 1% drop.

Stocks Performance
SFZN vs Swiss Market Index

Loading
SFZN
Swiss Market Index
Add Stock
www.alphaspread.com

Performance Gap
SFZN vs Swiss Market Index

Loading
SFZN
Swiss Market Index
Difference
www.alphaspread.com

Performance By Year
SFZN vs Swiss Market Index

Loading
SFZN
Swiss Market Index
Add Stock

Competitors Performance
Siegfried Holding AG vs Peers

Swiss Market Index
SFZN
0KHE
TMO
DHR
207940
Add Stock

Siegfried Holding AG
Glance View

Market Cap
4B CHF
Industry
Life Sciences Tools & Services

Nestled in the picturesque landscapes of Zofingen, Switzerland, Siegfried Holding AG operates as a key player in the global pharmaceutical supply chain, crafting a narrative of innovation and precision. With roots tracing back to 1873, this stalwart company has evolved over the decades, now standing as a leading supplier of active pharmaceutical ingredients (APIs) and finished dosage forms to the pharmaceutical industry. Siegfried's operations are defined by a seamless integration of chemistry and technology, embodying Swiss precision in every facet of its production process. The company's trajectory is marked by strategic expansions and acquisitions, allowing it to amass a presence in both Europe and North America, crafting a network that ensures its reliability and reach. At the heart of Siegfried's success lies its business model, a symbiotic partnership with pharmaceutical companies that rely on its vast expertise to bring their products to market. Siegfried essentially straddles both ends of the pharmaceutical value chain, deriving revenue by providing essential APIs as well as a robust offering of finished drugs. The company excels in tailor-made solutions, offering complex manufacturing processes that meet stringent regulatory demands. This dual capability not only diversifies its revenue streams but also buffers it against the volatile dynamics of the pharmaceutical industry. With a focus on quality and customer-centric innovation, Siegfried continues to carve a niche as a trusted collaborator, underpinning the development of health solutions worldwide.

SFZN Intrinsic Value
47.82 CHF
Overvaluation 48%
Intrinsic Value
Price
Back to Top